1-2 of 2
Diletta Fontana, PhD
Close
Sort by
Journal Articles

ETNK1 Mutations in Atypical Chronic Myeloid Leukemia Induce a Mutator Phenotype That Can be Reverted with Phosphoethanolamine

Diletta Fontana, PhD, Mario Mauri, PhD, Rossella Renso, MD, Mattia Docci, MD, Ilaria Crespiatico, MS, Lisa M Røst, PhD, Mi Jang, PhD, Antonio Niro, MS, Deborah D'Aliberti, PhD, Luca Massimino, PhD, Mayla Bertagna, MS, Giovanni Zambrotta, MD, Mario Bossi, MS, Stefania Citterio, MS, Barbara Crescenzi, PhD, Francesca Fanelli, PhD, Valeria Cassina, PhD, Roberta Corti, PhD, Domenico Salerno, PhD, Luca Nardo, PhD, Clizia Chinello, PhD, Francesco Mantegazza, PhD, Cristina Mecucci, MD PhD, Fulvio Magni, PhD, Guido Cavaletti, MD, Per Bruheim, PhD, Delphine Rea, MDPhD, Steen Larsen, PhD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2020) 136 (Supplement_2): LBA-5.
https://doi.org/10.1182/blood-2020-143852
Published: 2020
Journal Articles

Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients

Diletta Fontana, PhD, Daniele Ramazzotti, PhD, Andrea Aroldi, MD, Antonio Niro, MS, Luca Massimino, PhD, Delphine Rea, MD, Fabio Stagno, MD, Bruno Martino, MD, Leonardo Campiotti, MD, Giovanni Caocci, MD, Elena Maria Elli, MD, Monica Fumagalli, MD, Fabio Ciceri, MD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1714.
https://doi.org/10.1182/blood-2019-126467
Published: 2019